Pharma Industry News Weekly Recap: September 23, 2022

2022-09-23T09:28:50-07:00adipose, AI, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Pricing, FDA, Heart Failure, Insulin, Mergers, Obesity, Oncology, Women's Health|

// Biotech and Pharma Therapeutics Novo's Once-Weekly Insulin Treatment Part of a Transforming T2D Space September 22, 2022 [...]

Pharma Industry News Weekly Recap: September 16, 2022

2022-09-16T11:19:15-07:00adipose, AI, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Pricing, FDA, Heart Failure, Insulin, Mergers, Obesity, Oncology, Women's Health|

// Biotech and Pharma Therapeutics Eli Lilly touts early demand for high-stakes diabetes launch Mounjaro: analysts September 14, [...]

Pharma Industry News Weekly Recap: September 9, 2022

2022-09-16T11:20:00-07:00AI, Blockchain, Cancer, Cardiovascular, COVID-19, Diabetes, Digital Health, Drug Discovery, FDA, Insulin, Medical Marijuana, Mergers, Mobile Apps, Neuroscience, Obesity, Oncology, Wearables, Women's Health|

// Biotech and Pharma Therapeutics Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals September [...]

Pharma Industry News Weekly Recap: September 2, 2022

2022-09-16T11:21:10-07:00AI, Alzheimer's, Cancer, Cardiovascular, COVID-19, Diabetes, Digital Health, Digital Innovation, FDA, Gene Therapy, Heart Failure, Insulin, Mergers, Mobile Apps, Neuroscience, Obesity, Oncology, Private Equity & Venture Capital, San Diego Biotech, Wearables, Women's Health|

// Biotech and Pharma Therapeutics Novartis Nabs Merck Veteran to Helm BioMedical Institutes September 1, 2022 / Novartis / [...]

Pharma Industry News Weekly Recap: August 25, 2022

2022-09-01T17:58:54-07:004IR, AI, Alzheimer's, Biopharmaceutical Product Development, Blockchain, Breast Cancer, Cancer, Cell Therapy, CNS, Diabetes, Digital Health, Digital Innovation, Drug Pricing, FDA, Gene Therapy, Industry News, Insulin, Mergers, Metaverse, Mobile Apps, Oncology, Politics, Private Equity & Venture Capital, Regulatory, Research|

// Biotech and Pharma Therapeutics Backed by $40M, a biotech startup targets cancer with help from the immune [...]

Go to Top